Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019003098) TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING MICONAZOLE AND LULICONAZOLE OR SALTS THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/003098 International Application No.: PCT/IB2018/054693
Publication Date: 03.01.2019 International Filing Date: 26.06.2018
IPC:
A61K 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
Applicants:
ZENVISION PHARMA LLP [IN/IN]; First Floor, K. K. Chambers, SIR P. T. Road Fort, Maharashtra, Mumbai 400001, IN
Inventors:
BOBBA, Sivakumar, Venkata; IN
JADHAV, Bhimrao; IN
SHINDE, Dhananjay; IN
Agent:
MAJUMDAR, Subhatosh; IN
GANGULI, Dr., Sanchita; IN
SEN, Abhishek; IN
VENKATESH, Mythili; IN
MAJUMDAR, Amrita; IN
KUNDU, Subarna; IN
CHAUBEY, Priyanka; IN
Priority Data:
20172102279829.06.2017IN
Title (EN) TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING MICONAZOLE AND LULICONAZOLE OR SALTS THEREOF
(FR) COMPOSITION PHARMACEUTIQUE TOPIQUE COMPRENANT DU MICONAZOLE ET DU LULICONAZOLE OU DES SELS DE CEUX-CI
Abstract:
(EN) The present invention relates to topical pharmaceutical composition comprising i) miconazole or salts thereof; and ii) luliconzole or salts thereof. The composition is effective in the treatment of fungal infection. The topical pharmaceutical composition according to present invention provides synergism which broadens the spectrum of activity, enhance the rate or extent of killing (ex. through synergy), minimize development of resistance and reduce toxicities in the treatment of topical fungal infection.
(FR) La présente invention concerne une composition pharmaceutique topique comprenant i) du miconazole ou des sels de celui-ci; et ii) du luliconzole ou des sels de celui-ci. La composition est efficace dans le traitement d'une infection fongique. La composition pharmaceutique topique selon la présente invention fournit une synergie qui élargit le spectre d'activité, améliore le taux ou l'étendue de destruction (ex. par synergie), minimise le développement de résistance et réduit les toxicités dans le traitement d'une infection fongique topique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)